메뉴 건너뛰기
.. 내서재 .. 알림
소속 기관/학교 인증
인증하면 논문, 학술자료 등을  무료로 열람할 수 있어요.
한국대학교, 누리자동차, 시립도서관 등 나의 기관을 확인해보세요
(국내 대학 90% 이상 구독 중)
로그인 회원가입 고객센터 ENG
주제분류

추천
검색

논문 기본 정보

자료유형
학술저널
저자정보
유기연 (동덕여자대학교)
저널정보
한국임상약학회 한국임상약학회지 한국임상약학회지 제32권 제3호
발행연도
2022.9
수록면
178 - 184 (7page)
DOI
https://doi.org/10.24304/kjcp.2022.32.3.178

이용수

표지
📌
연구주제
📖
연구배경
🔬
연구방법
🏆
연구결과
AI에게 요청하기
추천
검색

초록· 키워드

오류제보하기
Background: Migraine is one of the leading causes of poor quality of life and disability, and migraine incidences in pediatrics areincreasing. Proper medication is important for the preventive and acute treatment of migraine. This study aimed to identify thecurrent status of prescribed medication in pediatric patients with migraine. Methods: We used data from a sample of pediatric patientsfrom the Health Insurance Review and Assessment Service (HIRA-PPS-2018) and analyzed the status of prescription drugs andfrequency of visits to medical institutions with migraine diagnoses in pediatric patients. Results: A total of 12,228 pediatric patientsdiagnosed with migraine during 2018 were analyzed. Among these patients, 7,170 (58.64%) were girls and 9,510 (77.77%) wereadolescents. Additionally, 9,157 patients (74.89%) received acute treatment, and 592 patients (4.84%) received combination therapywith analgesics and triptans. Acetaminophen for acute treatment and flunarizine for preventive treatment were the most commonlyprescribed. In most children and adolescents, acute treatment drugs were prescribed for less than 14 days. Conclusion: Analgesics,such as acetaminophen or non-steroidal anti-inflammatory drugs, were prescribed frequently for acute treatment in pediatric patientswith migraine. The drug prescription duration was within the recommended range, indicating a low risk of overdose. For preventivetreatment, clinically studied medication for pediatric patients with migraine was used.

목차

등록된 정보가 없습니다.

참고문헌 (0)

참고문헌 신청

함께 읽어보면 좋을 논문

논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!

이 논문의 저자 정보

최근 본 자료

전체보기

댓글(0)

0